identif
sever
acut
respiratori
syndromecoronaviru
sarscov
etiolog
agent
sar
led
scientist
develop
rapid
sensit
diagnost
test
although
sar
epidem
subsid
mani
author
includ
world
health
organ
center
diseas
control
prevent
cdc
warn
possibl
reemerg
highli
infecti
diseas
thu
sensit
test
sar
great
public
health
import
howev
number
diagnost
test
sensit
earli
phase
diseas
instanc
use
nasopharyng
aspir
use
earli
gener
reversetranscript
polymeras
chain
reaction
rtpcr
sarscov
sensit
diseas
sever
limit
restrict
abil
identifi
patient
prompt
manner
institut
isol
treatment
base
publicli
releas
full
genom
sequenc
sarscov
variou
molecular
detect
method
base
rtpcr
develop
pcrbase
diagnost
test
use
detect
sarscov
rna
patient
specimen
viral
rna
reversetranscrib
dna
differ
region
sarscov
genom
specif
amplifi
pcr
sever
rtpcr
protocol
develop
member
laboratori
network
avail
websit
http
wwwwhointcsrsar
primersen
rtpcr
mainli
divid
qualit
convent
quantit
approach
convent
rtpcr
approach
normal
qualit
natur
requir
timeconsum
contaminationpron
postpcr
analysi
realtim
quantit
rtpcr
overcom
mani
shortcom
increasingli
adopt
variou
laboratori
sar
diagnosi
suitabl
instrument
technolog
allow
data
record
analyz
pcr
cycl
furthermor
run
closedtub
system
postamplif
manipul
elimin
thu
methodolog
reduc
risk
contamin
minim
handson
time
entir
amplif
process
requir
h
allow
technolog
use
highthroughput
applic
sar
outbreak
pcrbase
test
sar
focus
mainli
analysi
nasopharyng
aspir
urin
stool
earli
studi
report
sarscov
rna
detect
nasopharyng
aspir
sar
patient
studi
mean
onset
ill
detect
rate
increas
studi
sarscov
rna
detect
stool
sampl
collect
mean
symptom
onset
similarli
viral
rna
detect
urin
sampl
collect
sar
patient
mean
onset
despit
high
sensit
stool
sampl
test
earli
detect
sarscov
still
suffer
lack
high
sensit
although
assay
predominantli
focus
rna
extract
nasopharyng
aspir
urin
stool
quantit
interpret
data
difficult
inabl
standard
data
result
numer
factor
sampl
techniqu
nasopharyng
aspir
urin
volum
variat
bowel
transit
time
eg
diarrhea
stool
consist
hand
plasmaserumbas
assay
may
allow
precis
standard
quantit
express
viral
load
thu
enabl
assess
diseas
sever
prognosi
detect
viral
nucleic
acid
plasmaserum
well
establish
viral
load
studi
numer
virus
begin
sar
outbreak
singl
report
show
rel
low
sensit
detect
sarscov
rna
plasma
use
ultracentrifugationbas
approach
low
concentr
sarscov
detect
plasma
patient
diseas
onset
subsequ
togeth
improv
viral
rna
extract
plasma
serum
requir
ultracentrifug
two
realtim
quantit
rtpcr
assay
one
aim
toward
polymeras
region
toward
nucleocapsid
region
viru
genom
fig
develop
measur
concentr
sarscov
rna
serumplasma
sampl
sar
patient
assay
absolut
calibr
curv
construct
serial
dilut
highperform
liquid
chromatographi
hplc
purifi
singlestrand
synthet
dna
oligonucleotid
specifi
studi
amplicon
fig
previou
studi
shown
singlestrand
oligonucleotid
reliabl
mimic
product
reversetranscript
step
produc
calibr
curv
ident
obtain
use
rna
use
calibr
methodolog
significantli
simplifi
process
obtain
calibr
curv
compar
laborintens
prepar
calibr
curv
involv
amplicon
subclon
vitro
transcript
sensit
amplif
step
assay
suffici
detect
copi
target
reaction
mixtur
correspond
copiesml
serum
use
rtpcr
assay
sarscov
rna
detect
serum
sampl
sar
patient
first
week
ill
studi
data
show
median
concentr
serum
sarscov
rna
patient
requir
intens
care
unit
icu
admiss
cours
hospit
significantli
higher
requir
intens
care
fig
quantit
test
thu
provid
viral
load
inform
allow
clinician
make
prognost
evalu
infect
individu
recent
report
reveal
clinic
cours
pediatr
sar
patient
less
sever
comparison
adult
sar
patient
whole
outcom
pediatr
sar
patient
favor
use
realtim
quantit
rtpcr
assay
sarscov
rna
recent
shown
detect
plasma
sampl
pediatr
patient
differ
stage
sar
fig
signific
differ
plasma
sarscov
viral
load
observ
pediatr
adult
sar
patient
taken
within
first
week
admiss
fever
onset
overal
viremia
appear
consist
featur
pediatr
adult
sar
patient
rel
high
detect
rate
sarscov
plasma
serum
first
week
ill
suggest
plasmaserumbas
rtpcr
incorpor
routin
diagnost
workup
suspect
confirm
sar
patient
adult
pediatr
popul
approach
open
numer
interest
research
opportun
exampl
assay
use
monitor
effect
lack
effect
antivir
agent
also
would
valuabl
explor
potenti
damag
effect
give
steroid
time
viral
load
still
rel
high
awar
mani
question
might
answer
retrospect
collect
sampl
nonetheless
develop
anim
model
might
allow
test
hypothes
control
manner
chapter
two
system
discuss
follow
base
develop
quantif
sarscov
rna
serum
sarsn
rtpcr
system
design
amplifi
nucleocapsid
region
system
design
amplifi
polymeras
region
viru
sarscov
rtpcr
system
use
earli
diagnosi
sar
provid
viral
load
inform
help
clinician
make
prognost
evalu
infect
individu
plain
collect
tube
serum
collectionrnas
away
invitrogen
carlsbad
ca
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
absolut
ethanol
primer
see
note
forward
bsarsn
iforward
duallabel
fluoresc
probe
see
note
fam
atggtcatgtgtggcggctcacta
tamra
fam
tgctagacagattgaaccagcttg
tamra
fam
tamra
amplicon
locat
sarsn
rtpcr
system
shown
fig
calibr
synthet
dna
oligonucleotid
correspond
part
polymeras
gene
sarscov
genom
hplcpurifi
proligo
singapor
see
note
dna
oligonucleotid
correspond
part
nucleocapsid
gene
sarscov
genom
hplcpurifi
proligo
singapor
see
note
rtth
rna
pcr
reagent
set
appli
biosystem
foster
citi
ca
abi
prism
sequenc
detector
appli
biosystem
high
sensit
rtpcrbase
approach
strict
precaut
appli
prevent
rtpcr
assay
contamin
precaut
includ
aerosolresist
pipet
tip
use
liquid
handlingsepar
area
use
rna
extract
step
set
amplif
reaction
addit
templat
carri
amplif
reactionsrealtim
pcr
approach
obviat
need
postpcr
process
reduc
risk
contaminationth
assay
includ
level
anticontamin
measur
form
preamplif
treatment
use
uracil
nglycosylas
destroy
carriedov
uracil
contain
pcr
product
multipl
neg
water
blank
includ
everi
analysi
detect
possibl
reagent
contamin
collect
blood
sampl
plain
tube
ensur
suffici
amount
serum
rna
analysi
least
ml
blood
taken
sampl
see
note
blood
sampl
process
soon
possibl
maxim
chanc
obtain
goodqual
viral
rna
process
procedur
take
place
immedi
blood
sampl
store
extra
care
see
note
centrifug
blood
sampl
min
serum
new
tubesstor
serum
rna
extract
see
note
rna
extract
perform
clean
separ
area
minim
chanc
crosscontamin
add
ml
avl
buffer
ml
serum
mix
incub
room
temperatur
minadd
ml
absolut
ethanol
mixtur
mixappli
mixtur
rneasi
mini
column
wash
column
accord
manufactur
recommendationsto
elut
rna
add
ave
buffer
onto
silicagel
membran
incub
min
room
temperatur
centrifug
rneasi
column
min
extract
rna
use
prepar
calibr
curv
serial
dilut
synthet
dna
oligonucleotid
specifi
amplicon
concentr
rang
copi
copi
see
note
set
rtpcr
reaction
mixtur
pol
n
gene
accord
tabl
add
sampl
rna
synthet
dna
oligonucleotid
calibr
curv
rnasefre
water
neg
blank
reaction
mixtureperform
realtim
rtpcr
reaction
abi
prism
sequenc
detector
cycl
condit
shown
tabl
amplif
data
analyz
store
sequenc
detect
system
softwar
appli
biosystem
sarscov
rna
concentr
express
copi
per
millilit
serum
copiesml
calcul
shown
follow
c
repres
sarscov
rna
concentr
serum
copi
ml
q
repres
target
quantiti
copi
determin
sequenc
detector
pcr
vrna
repres
total
volum
rna
obtain
extract
typic
vserum
repres
volum
serum
extract
typic
ml
valid
two
realtim
rtpcr
system
describ
previous
primer
probe
design
use
primer
appli
biosystem
certain
precaut
design
list
follow
amplicon
length
less
bp
ideal
longer
bp
short
amplicon
length
prefer
sever
reason
includ
synthet
oligonucleotid
specifi
amplicon
use
calibr
curv
commerci
avail
size
nucleotid
amplif
shorter
amplicon
length
effici
longer
amplicon
length
avoid
falseposit
result
aris
coamplif
gene
high
homolog
necessari
perform
blastn
search
primer
probe
sequenc
nation
center
biotechnolog
inform
ncbi
genbank
databas
result
search
provid
inform
regard
specif
amplif
vitrotranscrib
rna
use
calibr
curv
absolut
rna
quantif
vitrotranscrib
rna
usual
gener
subclon
amplicon
behind
rna
polymeras
promot
plasmid
vector
howev
procedur
laborintens
timeconsum
unsuit
larg
number
rtpcr
system
must
construct
short
period
time
altern
method
use
construct
calibr
curv
use
synthet
singlestrand
oligonucleotid
correspond
amplifi
sequenc
previou
data
shown
singlestrand
oligonucleotid
reliabl
mimic
product
revers
transcript
step
produc
calibr
curv
essenti
ident
obtain
use
rna
studi
reveal
ml
plasma
minim
sampl
volum
robust
detect
sarscov
rna
serum
thu
ml
blood
sampl
suffici
plain
blood
sampl
left
unprocess
correspond
serum
rna
concentr
fluctuat
time
artifactu
fluctuat
may
owe
sever
factor
releas
rna
necrot
andor
apoptot
blood
cell
stabil
origin
newli
releas
rna
guarante
reliabl
serum
rna
concentr
recommend
blood
sampl
store
process
soon
preanalyt
studi
signific
differ
viral
rna
concentr
observ
serum
store
unpublish
data
nonetheless
routin
store
serum
sampl
use
onestep
oneenzym
rtpcr
rtth
polymeras
sever
advantag
twoenzym
rtpcr
report
tth
polymeras
resist
inhibitor
present
biolog
specimen
taq
polymeras
rtth
polymeras
thermost
thu
allow
revers
transcript
perform
high
temperatur
therebi
minim
secondari
structur
present
rna
reversetranscript
pcr
carri
singl
tube
reduc
handson
time
risk
contamin
